Nebula Research & Development LLC

SEC CIK: 0001792635
Latest filing: May 15, 2026

SEC filings (opens in a new tab)

NRIX holding history

Nurix Therapeutics, Inc. in every 13F filed by Nebula Research & Development LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NRIX overview All 13F holders of NRIX Full Q1 2026 holdings

Shares (Q1 2024): 0; Sold out in Q1 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2023

Holdings of NRIX by Nebula Research & Development LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2024	0	$0	0.0%	−12,894−100.0%	Sold out	Holders
Q4 2023	12,894	$133.1K	<0.1%	+12,894	New	Holders
Q3 2023	0	$0	0.0%	−16,025−100.0%	Sold out	Holders
Q2 2023	16,025	$160.1K	0.1%	+16,025	New	Holders